This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • A Study of Atezolizumab and Tiragolumab Compared W...
Clinical trial

A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) (SKYSCRAPER-03)

Read time: 1 mins
Last updated:28th Mar 2021
Status: Recruiting
Identifier: NCT04513925
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest